BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 37771436)

  • 1. Cellular senescence: a double-edged sword in cancer therapy.
    Xiao S; Qin D; Hou X; Tian L; Yu Y; Zhang R; Lyu H; Guo D; Chen XZ; Zhou C; Tang J
    Front Oncol; 2023; 13():1189015. PubMed ID: 37771436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.
    Kallenbach J; Atri Roozbahani G; Heidari Horestani M; Baniahmad A
    Cell Biosci; 2022 Dec; 12(1):200. PubMed ID: 36522745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype.
    Kumari R; Jat P
    Front Cell Dev Biol; 2021; 9():645593. PubMed ID: 33855023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis.
    De Blander H; Morel AP; Senaratne AP; Ouzounova M; Puisieux A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Senescence in the Lung: The Central Role of Senescent Epithelial Cells.
    Hansel C; Jendrossek V; Klein D
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence.
    Liao C; Xiao Y; Liu L
    Cancer Manag Res; 2020; 12():13553-13566. PubMed ID: 33408525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.
    Battram AM; Bachiller M; Martín-Antonio B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence and tumor suppression.
    Hinds P; Pietruska J
    F1000Res; 2017; 6():2121. PubMed ID: 29263785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.
    Piskorz WM; Cechowska-Pasko M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
    Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
    Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Jekyll and Hyde of Cellular Senescence in Cancer.
    Demirci D; Dayanc B; Mazi FA; Senturk S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence and Cancer.
    Zeng S; Shen WH; Liu L
    Cancer Transl Med; 2018; 4(3):70-74. PubMed ID: 30766922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer.
    Banerjee P; Kotla S; Reddy Velatooru L; Abe RJ; Davis EA; Cooke JP; Schadler K; Deswal A; Herrmann J; Lin SH; Abe JI; Le NT
    Front Cardiovasc Med; 2021; 8():763930. PubMed ID: 34746270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.